METHODS AND COMPOSITIONS FOR INHIBITING RHO/MRTF-MEDIATED DISEASES AND CONDITIONS
申请人:THE REGENTS OF THE UNIVERSITY OF MICHIGAN
公开号:US20150250769A1
公开(公告)日:2015-09-10
The present disclosure relates to methods, compositions, and kits for the inhibition of signaling by members of the Rho GTPase family. Specifically, the disclosure relates to methods, compositions and kits for the inhibition of RhoA and/or RhoC transcriptional signaling and action of the transcription co-factors MRTF-A and/or MRTF-B. The disclosure finds use in treatment of Rho-mediated disease states (e.g., tumor metastasis and fibrosis), Rho-mediated biological conditions, and in cell signaling research.
5-Aryl-1,3,4-oxadiazoline-2(3H)-thiones in reactions with alkyl haloacetates
作者:A. A. Ziyaev、I. F. Tozhiev、Kh. M. Shakhidoyatov
DOI:10.1007/s10593-012-1020-4
日期:2012.6
The reaction of 5-aryl-1,3,4-oxadiazoline-2(3H)-thiones with alkyl haloacetates has been studied. It was shown that the reaction proceeds to give S-substituted products. The effect of the nature of the substituents in the molecules of both the thiones and the haloacetates on the reaction route and yields has been examined.